Pharmacy Compounding Inspection Procedure Change Notice- Drug Information Update

The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.

FDA posted a notice announcing a change in its procedure for inspections of certain human drug compounders, which will take effect on August 1, 2016. FDA is making this change in response to stakeholder input.

Should you have questions, please contact compounding@fda.hhs.gov.